Background: Off-pump coronary artery bypass surgery and sirolimus-eluting stent placement have been widely used for the treatment of coronary artery disease. The goal of this study was to compare long-term outcomes after off-pump coronary artery bypass surgery or sirolimus-eluting stent placement in diabetic patients with multivessel disease. Methods: This observational study enrolled 350 off-pump coronary artery bypass patients and 143 sirolimus-eluting stent patients receiving care at our institution between 2000 and 2007. All patients had diabetes and multivessel disease including proximal left anterior descending or left main coronary artery. The choice of revascularization (percutaneous coronary intervention versus coronary artery bypass surgery) was left to the physician's discretion rather than randomization. Cox proportional-hazard analyses, adjusting baseline risk factors and propensity score, which predicted the probability of receiving off-pump coronary artery bypass, were conducted to evaluate outcomes, including all-cause mortality, cardiac death, target vessel revascularization, and major adverse cardiac and cerebrovascular events. Results: During the follow-up (2.6 ± 1.6 years) period, there was no difference between offpump coronary artery bypass and sirolimus-eluting stent placement in all-cause mortality or cardiac death. However, the incidences of acute coronary syndrome, target vessel revascularization, and major adverse cardiac and cerebrovascular events were markedly lower in the patients undergoing off-pump coronary artery bypass than in those receiving sirolimus-eluting stent placement. * Corresponding author at: Department of Cardiovascular Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan. Tel.: +81 3 5802 1056; fax: +81 3 5689 0627.
Introduction
Coronary artery disease is the major cause of mortality in patients with diabetes mellitus. In fact, diabetes patients have a threefold higher risk of mortality from coronary artery disease when compared with non-diabetic subjects [1] . Furthermore, patients with diabetes undergoing revascularization have increased mortality when compared with non-diabetic patients.
Previous clinical studies have demonstrated that coronary artery bypass surgery (CABG) produced superior outcomes in diabetic patients when compared with percutaneous coronary intervention (PCI) [2] . However, these studies compared conventional CABG to bare-metal stents and did not study off-pump coronary artery bypass surgery (OPCAB) or drug-eluting stents (DES). This is an important limitation of previous studies, as OPCAB is less invasive, uses all in situ conduits, and employs aorta no-touch techniques, which results in a decreased incidence of intraoperative complications and in improvements in long-term outcomes. Further, DES are associated with a decreased incidence of restenosis after PCI when compared with bare-metal stents.
Thus, the goal of this study was to compare long-term outcomes after OPCAB versus PCI with DES in diabetic patients with multivessel coronary artery disease.
Patients and methods

Patients
Data from consecutive patients with type 2 diabetes and multivessel coronary artery disease who underwent revascularization with placement of sirolimus-eluting stents (Cypher, Johnson & Johnson, Miami Lakes, FL, USA) (SES-PCI group) or OPCAB surgery (OPCAB group) at the Juntendo Heart Center (Tokyo, Japan) from July 2002 to December 2008 were analyzed. The management of patient data was performed according to the ethics policies of our institution, and this study was approved by the ethics review board of our institution. Written informed consent was obtained from all patients. Multivessel disease was defined as 75% stenosis in more than two major epicardial vessels with proximal LAD or left main trunk.
A total of 493 patients, including 350 patients who underwent OPCAB between July 2002 and December 2008 and 143 patients who underwent PCI using SES between 2004 and 2008, met the inclusion criteria for this study. Diabetes mellitus was defined as a fasting plasma glucose level ≥126 mg/dl, treatment with oral hypoglycemic medication, or insulin use. Hypertension was defined as systolic blood pressure (BP) ≥140 mmHg or diastolic BP ≥90 mmHg, or treatment with specific antihypertensive medications. Chronic kidney disease was defined as glomerular filtration rate <60 ml/min/1.73 m 2 , calculated by the Modification of Diet in Renal Disease equation, or chronic dialysis treatment. A current smoker was defined as a patient who was still smoking before hospital admission or who stopped smoking within 1 year prior to the procedure.
Revascularization procedure
PCI with SES was performed using standard techniques. Treatment with aspirin (100 mg/day) and clopidogrel (75 mg) or ticlopidine (200 mg/day) was initiated 72 h before PCI and was continued indefinitely. Heparin was administered during the procedure to maintain an activated clotting time >250 s. All patients were scheduled for angiographic follow-up at 10 months, or earlier if angina symptoms occurred. OPCAB was carried out according to internationally established techniques. Arterial conduits were used whenever possible. After surgery, antiplatelet therapy with aspirin (100 mg/day) was continued indefinitely. All patients were scheduled for angiographic or coronary computed tomography evaluation at 1 year after revascularization, or earlier if angina symptoms occurred.
Outcomes
Outcomes assessed in this study were all-cause mortality, cardiac death, target vessel revascularization, acute coronary syndrome (ACS), and major adverse cardiac and cerebrovascular events (MACCE). Death from myocardial infarction, arrhythmia, congestive heart failure, or sudden death was defined as cardiac death. Target vessel revascularization was defined as repeated PCI or coronary artery bypass surgery of the target-vessel, driven by clinical symptoms of myocardial ischemia, or an in-lesion stenosis of more than 75% of the reference luminal diameter by visual estimate. ACS included ACS with ST elevation which was defined by the presence of ≥1 mm ST elevation in at least two adjacent limb leads, ≥2 mm ST elevation in at least two contiguous precordial leads, or new onset left bundle branch block, and ACS without ST elevation defined as present of the triad of clinical presentation (including a history of coronary artery disease), electrocardiographic changes, and biochemical cardiac markers. MACCE included cardiac death, cerebrovascular accident, stroke, myocardial infarction, and target vessel revascularization. Survival data and occurrence of adverse events were collected by serial contacts with the patients or their families either by telephone interview or questionnaires sent every year. The details of mode of death were obtained from the medical records of hospitals or by direct contact with private physicians. The database search was performed at the end of 2008, and a common closing day of December 31, 2008 was used for analysis.
Statistical analysis
For comparison of patients' characteristics, categorical data are tabulated as frequencies and percentages, and continuous variables are expressed as mean ± SD. These data were analyzed using Chi-square tests or Student's t-tests. Survival curves of both OPCAB and SES-PCI groups were constructed by Kaplan-Meier methods and were compared by log-rank test. Cox proportional hazards models were constructed for unadjusted and adjusted survival analyses.
Propensity analysis was applied to adjust variables that would have been related to the decision regarding revascularization procedure and to identify patients with similar probabilities of undergoing OPCAB based on observed clinical characteristics. Propensity scores were then calculated for each patient from the results of the multivariate logistic regression hazard analysis. The propensity scores were entered into the Cox proportional hazard model as continuous variables along with the baseline covariates. A higher propensity score indicated a higher probability of undergoing OPCAB at baseline. Among 17 variables [age, gender, use of oral hypoglycemic agent, use of insulin, presence of hypertension, current smoker, hemodialysis, family history of coronary artery disease, prior history of myocardial infarction, presence of ACS, left ventricular ejection fraction (%), three-vessel disease, left main trunk lesion, serum low-density lipoprotein (mg/dl), serum creatinine (mg/dl), and hemoglobin A1c (%)], covariates with a p-value less than 0.20 in the univariate analysis of each endpoint were selected for the multivariate Cox proportional hazard analyses with propensity score. The proportional hazard assumption was checked by including the interaction term between OPCAB and other covariates in this model. Hazard ratios (HRs) and confidence intervals (CIs) of OCPAB were calculated. A p-value of <0.05 was considered to indicate an independent risk factor. All reported p-values are two-tailed. All statistical analyses were performed using SPSS version 15.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Baseline characteristics
All consecutive patients, who had revascularization during the study period, completed follow-up. Baseline characteristics and clinical events during the follow-up period (2.7 ± 1.6 years) were collected for all patients. Of the 399 enrolled patients, 140 (35%) and 259 (65%) underwent SES-PCI and OPCAB, respectively. Baseline characteristics of the two groups are summarized in Table 1 . Patients who underwent OPCAB were likely to have more severe coronary artery disease and were significantly younger than those who underwent SES-PCI. Patients undergoing OPCAB were more likely to have a history of cerebrovascular accident and hypertension and have significantly higher fasting blood sugar and hemoglobin A1c than patients undergoing SES-PCI. None of the other variables were significantly different when comparing the two groups.
Propensity analysis
The variables used to calculate propensity score were age, gender, history of cerebrovascular events, number of diseased vessels, and left main trunk disease. The property of the propensity score was checked, since the area under the receiver operating characteristics (ROC) curve was 0.80 (95% CI, 0.76-0.84, p > 0.001), indicating excellent discrimination. The Hosmer-Lemeshow goodness of fit 2 for this model was 7.21 (p = 0.52). A higher propensity score in the present study indicated an increased likelihood of undergoing OPCAB. OPCAB patients had a lower mean propensity score than SES-PCI patients (0.22 ± 0.19 versus 0.43 ± 0.18).
Outcomes
A total of 31 patients died from any cause, and 7 patients died from cardiac causes. A total of 11 patients experienced ACS after revascularization, 23 patients underwent target vessel revascularization, and 52 patients had MACCE. Cumulative survival curves of each endpoint are shown in Fig. 1 . All-cause and cardiac mortality rates did not significantly differ between OPCAB group and SES-PCI group. In addition, there was no difference in stroke between the two groups. However, ACS, target vessel revascularization, and MACCE were significantly lower in the OPCAB group than in the SES-PCI group. The results of Cox proportional hazard model adjusted for baseline covariates and propensity score are shown in Table 2 . There was no difference in allcause mortality (HR, 1.45; 95% CI, 0.0.47-4.42; p = 0.51) or cardiac mortality (HR, 2.30; 95% CI, 0.19-27.3; p = 0.51) between the two groups. However, adjusted hazards of ACS and target vessel revascularization were significantly lower in the OPCAB group than in the SES-PCI group (HR, 0.28; 95% CI, 0.01-0.18; p < 0.0001; and HR, 0.08; 95% CI, 0.02-0.30; p < 0.0001). In addition, the incidence of the composite endpoint, MACCE, was also significantly lower in the OPCAB group than in the SES-PCI group (HR, 0.14; 95% CI, 0.06-0.30; p < 0.0001).
Discussion
The prevalence of diabetes continues to increase worldwide. This diagnosis is associated with complicated coronary artery lesions, small vessel reference diameter, diffuse disease, longer lesion length, and rapid progression of lesions, all of which lead to worse outcomes. Prior clinical trials have demonstrated that hard outcomes, including death and myocardial infarction, were similar when comparing CABG and PCI but that target vessel revascularization and angina relief were superior with CABG when compared with PCI [3] [4] [5] . Other previous clinical trials demonstrated that CABG resulted in favorable revascularization and reduction of death and myocardial infarction in diabetic patients [6] , and thus this approach has been the standard of care for diabetic patients with multivessel coronary artery disease. In addition, this study firstly revealed superiority of CABG in terms of incidence of ACS when compared to PCI using DES.
However, recent refinements in PCI and CABG strategies may be changing the paradigm for coronary revascularization procedures in patients with diabetes. For example, use of DES has remarkably reduced restenosis and target vessel revascularization [7] [8] [9] when compared with BMS, while OPCAB is less invasive and is associated with a shorter operating time, and lower rates of stroke in complicated patients when compared with traditional CABG [10, 11] . Thus, either of these advanced methods should result in improvements in mortality, myocardial infarction, and target vessel revascularization. The present study demonstrated that outcomes in terms of MACCE, target vessel revascularization, and ACS were better with OPCAB than with SES-PCI in diabetic patients with multivessel coronary artery disease. However, there were no significant differences in the incidence of all-cause mortality, cardiac death on adverse events other than target vessel revascularization and ACS when comparing OPCAB and SES-PCI. These observations are consistent with those from previous clinical studies that assessed conventional CABG versus PCI with plain old balloon angioplasty or BMS [6, 12] , in which CABG produced better outcomes in diabetic patients. Further, Briguori et al. reported that 1-year outcomes were better with OPCAB than with SES [13] , but interpretation of this study was limited by the short follow-up time period and the low number of complete revascularizations in the SES group. In contrast, Yamagata et al. reported that 3-year composite endpoints were similar when comparing OPCAB and SES [14] . This study differed from the present study in several factors, including the fact that it was an observational study, primary endpoints were different, and that multivessel disease was defined as stenosis >75% in diameter in more than two major epicardial vessels as opposed to >75% stenosis in more than two major epicardial vessels with proximal LAD or left main trunk. Differences in baseline characteristics, such as more severe coronary disease, could explain the worse outcomes in our patients with SES compared to OPCAB. This finding was consistent with results from the SYNTAX trial, which demonstrated that patients with high SYNTAX score (i.e. severe coronary artery disease) who underwent CABG had a lower rate of cardiac events with compared with patients that received a DES [15, 16] .
Japan is the only country in which >60% of isolated coronary artery bypass surgeries are performed without cardiopulmonary bypass; OPCAB is only used about 30% of the time in Western countries and in other Asian countries. This may be because a previous study reported that OPCAB was not significantly superior to conventional CABG in terms of clinical outcomes and cost-effectiveness [17] . However, several other clinical trials reported that OPCAB was associated with decreased postoperative morbidity in high-risk patients when compared with conventional CABG [10, 11] , and another study indicated that the beneficial effect of OPCAB extended beyond only those patients who were at high-risk for complications. Indeed, Hirose et al. demonstrated that the OPCAB reduced the risk of postoperative mortality and morbidity, as represented by the EuroSCORE [18] , regardless of baseline patient characteristics.
PCI is used for patients with more severe coronary artery disease in Japan when compared with Western countries. In some cases, patients with LMT lesions, three-vessel disease, or chronic total occlusion are treated with PCI in Japan. The increased utilization of PCI in Japan has led Japanese surgeons to adopt less invasive surgical procedures (e.g. OPCAB) in order to produce outcomes that are superior to those achieved with PCI. In fact, OPCAB is now the standard procedure utilized in Japan and produces outcomes that are comparable or superior to conventional CABG. Indeed, outcomes with OPCAB in the present study (2-year mortality of 10%) are much better than historical results with CABG in diabetic patients with multivessel coronary artery disease (2-year mortality of 20%). This may be partially due to the fact that OPCAB utilizes arterial conduits or because the cohort in the present study benefited from advances in medical therapy.
The better outcomes in response to OPCAB relative to SES in diabetic patients with multi-vessel disease can be explained by the presence of more severe diffuse disease in diabetic patients and by the effects of disease progression. Despite medical therapy, coronary artery disease can progress in both native coronary arteries and bypass conduits; however, grafting literally bypasses the existing lesion and any other future culprit lesions within the diseased vessel, canceling out the effects of lesion progression within the bypassed segment [19, 20] . In contrast, stenting does not modulate lesion progression anywhere else within the diseased vessel.
This study has several limitations. First, it was nonrandomized and used observational data from a single center well-managed database. We tried to minimize the bias inherent in observational studies by using multivariate analysis and propensity analysis. However, other unknown confounders may have affected the outcomes. Second, the choice of specific revascularization therapy was left to the discretion of the interventional cardiologists and cardiac surgeons, and the absence of randomization may have confounded the results. For example, higher-risk patients (e.g. diffuse disease or left ventricular dysfunction) that are not traditionally considered as good candidates for OPCAB may have been selected for OPCAB nonetheless. Third, given the risk of very late thrombosis with SES, a longer-term clinical follow-up is needed to assess the clinical safety of DES in these patients. We tried to minimize this effect by computing a propensity score and including it in our calculation of the HR.
In conclusion, OPCAB was superior to SES-PCI in terms of ACS, target vessel revascularization, and MACCE in diabetic patients with multivessel coronary artery disease. Further prospective study is needed to elucidate the relative longterm outcomes of these two procedures.
